Masavibart [2640223-84-1]

TargetMol Chemicals

Masavibart

9

2640223-84-1

Antibody

Research Use Only

Masavibart

Masavibart (ZRC3308-A7), an IgG1 type anti-SARS-CoV-2 monoclonal antibody, demonstrates strong binding affinity for a distinct non-competing epitope located on the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. When paired in a 1:1 ratio with ZRC3308-B10, Masavibart is efficacious in preventing COVID-19, particularly in its early stages before the onset of severe symptoms [1].

3 years

-20°C

12352203